株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

培養皮膚 (代用皮膚) 市場の予測:種類別 (無細胞、同種細胞、自家細胞など)、用途別、地域別

Tissue Engineered - Skin Substitutes Market: By Type (Acellular, Cellular Allogeneic, Cellular Autologous, Others); By Application (Burn Injury, Diabetic/Vascular Ulcer and Others); & By Region - 2019-2024

発行 IndustryARC 商品コード 422696
出版日 ページ情報 英文
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=112.95円で換算しております。
Back to Top
培養皮膚 (代用皮膚) 市場の予測:種類別 (無細胞、同種細胞、自家細胞など)、用途別、地域別 Tissue Engineered - Skin Substitutes Market: By Type (Acellular, Cellular Allogeneic, Cellular Autologous, Others); By Application (Burn Injury, Diabetic/Vascular Ulcer and Others); & By Region - 2019-2024
出版日: 2018年12月14日 ページ情報: 英文
概要

当レポートでは、世界の培養皮膚 (代用皮膚) 市場について調査分析し、市場情勢、市場力学、戦略的分析、市場分析 (セグメント別) のほか、主要企業などについて、体系的な情報を提供しています。

第1章 培養皮膚 (代用皮膚) 市場:概要

第2章 エグゼクティブサマリー

第3章 培養皮膚 (代用皮膚) 市場:情勢

  • 市場シェア分析
  • 比較分析
  • 製品ベンチマーキング
  • エンドユーザープロファイル
  • 財務分析トップ5

第4章 培養皮膚 (代用皮膚) 市場:力学

  • 促進要因
  • 抑制要因
  • 機会
  • 課題
  • ファイブフォース分析

第5章 培養皮膚 (代用皮膚) 市場:戦略的分析

  • バリューチェーン分析
  • 価格分析
  • 機会分析
  • 製品/市場ライフサイクル分析
  • 供給業者・流通業者

第6章 培養皮膚 (代用皮膚) 市場:種類別

  • 無細胞
  • 同種細胞
  • 自家細胞
  • その他

第7章 培養皮膚 (代用皮膚) 市場:用途別

  • 火傷
  • 糖尿病性/血管性潰瘍
  • その他

第8章 培養皮膚 (代用皮膚) 市場:地域別

  • 欧州
  • アジア太平洋地域
  • 北米
  • その他

第9章 培養皮膚 (代用皮膚) 市場:エントロピー

第10章 企業プロファイル

  • Acelity L.P., Inc.
  • BSN medical
  • Integra LifeSciences Corporation
  • Medtronic (Covidien)
  • Molnlycke Health Care
  • Smith & Nephew plc
  • Organogenesis, Inc.
  • ConVatec
  • 3m Healthcare
  • Integra LifeSciences Corporation

第11章 付録

目次

Skin substitutes are cellular and acellular material which help in aiding in the healing of damaged skin by releasing cytokines and growth factors at the wound site. These skin substitutes or artificial skin substitute are derived from human tissue, non-human tissue, synthetic materials, and combination of the above materials and are grafted on the injured part. Globally, growing cases of skin related injuries and growing medical tourism to low cost destinations is expected to remain one of the key growth driver during the period of study.

Geographically, North America dominated the tissue engineered - skin substitutes market driven by world class healthcare infrastructure with technological advanced practice, higher spending and presence of key industry players in the region. North America was followed by Europe and Asia-Pacific as second and third largest market for tissue engineered - skin substitutes market. Asia Pacific is projected to have the fastest growth, owing to rapidly developing medical infrastructure, increasing spending on healthcare and growing medical tourism in developing nations such as China and India in this region.

This report identifies the tissue engineered - skin substitutes market size for the years 2014-2016, and forecast of the same till the year 2022. It also highlights the market drivers, restraints, growth indicators, challenges, and other key aspects with respect to the tissue engineered - skin substitutes market.

This report segments the tissue engineered - skin substitutes market on the basis of type, application and regional market as follows:

Tissue Engineered - Skin Substitutes market research report is classified on the basis of type. Some of the major types covered in this report are as follows: Acellular, Cellular Allogeneic, Cellular Autologous, Others.

Tissue Engineered - Skin Substitutes market research report is classified on the basis of application. Some of the major applications covered in this report are as follows: Burn Injury, Diabetic/Vascular Ulcer and Others.

This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region.

This report identifies all the major companies operating in the tissue engineered - skin substitutes market. Some of the major companies' profiles in detail are as follows:

Acelity L.P., Inc.

BSN medical

Integra LifeSciences Corporation

Medtronic (Covidien)

Molnlycke Health Care

1. Tissue Engineered - Skin Substitutes Market - Overview

2. Executive Summary

3. Tissue Engineered - Skin Substitutes Market Landscape

  • 3.1. Market Share Analysis
  • 3.2. Comparative Analysis
  • 3.3. Product Benchmarking
  • 3.4. End User Profiling
  • 3.5. Top 5 Financials Analysis

4. Tissue Engineered - Skin Substitutes Market- Forces

  • 4.1. Drivers
    • 4.1.1. Rise in Geriatric Population
    • 4.1.2. Increasing Incidence rate of Skin disorders
  • 4.2. Restraints
    • 4.2.1. High cost
  • 4.3. Opportunities
  • 4.4. Challenges
  • 4.5. Porter's Five Forces Analysis
    • 4.5.1. Bargaining Power of Suppliers
    • 4.5.2. Bargaining Power of Buyers
    • 4.5.3. Threat of New Entrants
    • 4.5.4. Threat of Substitutes
    • 4.5.5. Degree of Competition

5. Tissue Engineered - Skin Substitutes Market- Strategic Analysis

  • 5.1. Value Chain Analysis
  • 5.2. Pricing Analysis
  • 5.3. Opportunities Analysis
  • 5.4. Product/Market Life Cycle Analysis
  • 5.5. Suppliers and Distributors

6. Tissue Engineered - Skin Substitutes Market, By Type

  • 6.1. Acellular
  • 6.2. Cellular Allogeneic
  • 6.3. Cellular Autologous
  • 6.4. Others

7. Tissue Engineered - Skin Substitutes Market, By Application

  • 7.1. Burn Injury
  • 7.2. Diabetic/Vascular Ulcer
  • 7.3. Others

8. Tissue Engineered - Skin Substitutes Market, By Geography

  • 8.1. Europe
    • 8.1.1. Germany
    • 8.1.2. France
    • 8.1.3. Italy
    • 8.1.4. Spain
    • 8.1.5. Russia
    • 8.1.6. U.K.
    • 8.1.7. Rest of Europe
  • 8.2. Asia Pacific
    • 8.2.1. China
    • 8.2.2. India
    • 8.2.3. Japan
    • 8.2.4. South Korea
    • 8.2.5. Rest of Asia-Pacific
  • 8.3. North America
    • 8.3.1. U.S.
    • 8.3.2. Canada
    • 8.3.3. Mexico
  • 8.4. Rest of the World (RoW)
    • 8.4.1. Brazil
    • 8.4.2. Rest of RoW

9. Tissue Engineered - Skin Substitutes Market - Entropy

  • 9.1. Expansion
  • 9.2. Technological Developments
  • 9.3. Merger & Acquisitions, and Joint Ventures
  • 9.4. Supply- Contract

10. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)

  • 10.1. Acelity L.P., Inc.
  • 10.2. BSN medical
  • 10.3. Integra LifeSciences Corporation
  • 10.4. Medtronic (Covidien)
  • 10.5. Molnlycke Health Care
  • 10.6. Smith & Nephew plc
  • 10.7. Organogenesis, Inc.
  • 10.8. ConVatec
  • 10.9. 3m Healthcare
  • 10.10. Integra LifeSciences Corporation

More than 40 Companies are profiled in this Research Report, Complete List available on Request*

"*Financials would be provided on a best efforts basis for private companies"

11. Appendix

  • 11.1. Abbreviations
  • 11.2. Sources
  • 11.3. Research Methodology
  • 11.4. Bibliography
  • 11.5. Compilation of Expert Insights
  • 11.6. Disclaimer
Back to Top